Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 2

Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.

7,994 public trials 713 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 2 trial results

Completed

Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes

NCT00097084

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Little Rock, Arkansas, United States
  • Novo Nordisk Investigational Site Inglewood, California, United States
  • Novo Nordisk Investigational Site San Francisco, California, United States
  • Novo Nordisk Investigational Site Santa Ana, California, United States
View all 60 locations
View Trial Details
Completed

Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes

NCT00283751

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Greenbrae, California, United States
  • Novo Nordisk Investigational Site La Mesa, California, United States
  • Novo Nordisk Investigational Site West Palm Beach, Florida, United States
  • Novo Nordisk Investigational Site Atlanta, Georgia, United States
View all 96 locations
View Trial Details
Completed

Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.

NCT02288273

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • Research Site Anaheim, California, United States
  • Research Site Chino, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site North Hollywood, California, United States
View all 29 locations
View Trial Details
Completed

A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker

NCT01137474

Conditions
Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
Locations
  • University Of Alabama At Birmingham Birmingham, Alabama, United States
  • Horizon Research Group, Inc. Mobile, Alabama, United States
  • Iicr, Inc. (International Institute Of Clinical Research) Ozark, Alabama, United States
  • Hope Research Institute Phoenix, Arizona, United States
View all 329 locations
View Trial Details
Completed

Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

NCT00331851

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Bahía Blanca, Argentina
  • Novo Nordisk Investigational Site Ciudad Autonoma de Bs As, Argentina
  • Novo Nordisk Investigational Site Junín, Argentina
  • Novo Nordisk Investigational Site Mendoza, Argentina
View all 116 locations
View Trial Details
Completed

Safety of Liraglutide in Pediatric Patients With Type 2 Diabetes

NCT00943501

Conditions
Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
Locations
  • Novo Nordisk Investigational Site Cypress, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Los Angeles, California, United States
  • Novo Nordisk Investigational Site Aurora, Colorado, United States
View all 20 locations
View Trial Details

Related conditions